These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18724572)

  • 1. The prevalence of borderline personality among buprenorphine patients.
    Sansone RA; Whitecar P; Wiederman MW
    Int J Psychiatry Med; 2008; 38(2):217-26. PubMed ID: 18724572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of binge eating disorder and borderline personality symptomatology among gastric surgery patients.
    Sansone RA; Schumacher D; Wiederman MW; Routsong-Weichers L
    Eat Behav; 2008 Apr; 9(2):197-202. PubMed ID: 18329598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional imaging of emotion reactivity in opiate-dependent borderline personality disorder.
    Smoski MJ; Salsman N; Wang L; Smith V; Lynch TR; Dager SR; LaBar KS; Linehan MM
    Personal Disord; 2011 Jul; 2(3):230-41. PubMed ID: 22448769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruptive behaviors in the medical setting and borderline personality.
    Sansone RA; Farukhi S; Wiederman MW
    Int J Psychiatry Med; 2011; 41(4):355-63. PubMed ID: 22238840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine treatment: a three-year prospective study in opioid-addicted patients of a public out-patient addiction center in Milan.
    Cozzolino E; Guglielmino L; Vigezzi P; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L
    Am J Addict; 2006; 15(3):246-51. PubMed ID: 16923672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The abuse of prescription medications: borderline personality patients in psychiatric versus non-psychiatric settings.
    Sansone RA; Wiederman MW
    Int J Psychiatry Med; 2009; 39(2):147-54. PubMed ID: 19860073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of childhood trauma among those seeking buprenorphine treatment.
    Sansone RA; Whitecar P; Wiederman MW
    J Addict Dis; 2009; 28(1):64-7. PubMed ID: 19197597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of borderline personality disorder and its clinical correlates in Chinese patients with recent deliberate self-harm.
    Wong HM; Leung HC; Chow LY; Kam WK; Tang AK
    J Pers Disord; 2010 Dec; 24(6):800-11. PubMed ID: 21158601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.
    Mendelson J; Flower K; Pletcher MJ; Galloway GP
    Exp Clin Psychopharmacol; 2008 Oct; 16(5):435-41. PubMed ID: 18837640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between older and younger adults with borderline personality disorder on clinical presentation and impairment.
    Morgan TA; Chelminski I; Young D; Dalrymple K; Zimmerman M
    J Psychiatr Res; 2013 Oct; 47(10):1507-13. PubMed ID: 23866737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure.
    Korzekwa MI; Dell PF; Links PS; Thabane L; Webb SP
    Compr Psychiatry; 2008; 49(4):380-6. PubMed ID: 18555059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of psychiatric outpatients for borderline personality disorder with the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD).
    Melartin T; Häkkinen M; Koivisto M; Suominen K; Isometsä ET
    Nord J Psychiatry; 2009 Nov; 63(6):475-9. PubMed ID: 19548177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline personality symptomatology and legal charges related to drugs.
    Sansone RA; Watts DA; Wiederman MW
    Int J Psychiatry Clin Pract; 2014 Jun; 18(2):150-2. PubMed ID: 24059849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of nalmefene in patients with comorbid borderline personality disorder and alcohol use disorder: a preliminary report.
    Martín-Blanco A; Patrizi B; Soler J; Gasol X; Elices M; Gasol M; Carmona C; Pascual JC
    Int Clin Psychopharmacol; 2017 Jul; 32(4):231-234. PubMed ID: 28181957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline personality disorder features and risk for prescription opioid use disorders.
    Tragesser SL; Jones RE; Robinson RJ; Stutler A; Stewart A
    J Pers Disord; 2013 Aug; 27(4):427-41. PubMed ID: 23718741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
    Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
    Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Attachment Patterns in Patients With Comorbid Borderline Personality and Substance Use Disorders.
    Schindler A; Sack PM
    J Nerv Ment Dis; 2015 Nov; 203(11):820-6. PubMed ID: 26488917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of borderline personality disorder in a sample of French high school students.
    Chabrol H; Montovany A; Chouicha K; Callahan S; Mullet E
    Can J Psychiatry; 2001 Nov; 46(9):847-9. PubMed ID: 11761637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heightened subjective experience of depression in borderline personality disorder.
    Stanley B; Wilson ST
    J Pers Disord; 2006 Aug; 20(4):307-18. PubMed ID: 16901256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.